Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment Life Science Investing
RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Oncology Annual Scientific Meeting Life Science Investing
Spruce Biosciences Announces Data Presentations at the 22nd Annual WORLDSymposium Life Science Investing
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson's Disease Life Science Investing
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Life Science Investing
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation Biotech Investing
Biogen's Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options Life Science Investing
Exelixis to Release Fourth Quarter and Fiscal Year 2025 Financial Results on Tuesday, February 10, 2026 Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
